Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital’s Top Stock Picks
We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take ...
CAPLYTA’S Strong Market Adoption Propels Its Rise As A Leading Antipsychotic Therapy | Delveinsight
Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...
Bausch Health projects $4.95B-$5.1B revenue for 2025 with focus on growth and innovation
Discover Bausch Health's Q4 2024 earnings highlights, showcasing revenue growth, strategic pillars, and key segment performance.
DelveInsight Business Research, LLP: Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...